Literature DB >> 21984036

Regulation of PMA-induced MUC5AC expression by heparin in human bronchial epithelial cells.

Qi Li1, Rui Xia Lei, Xiang Dong Zhou, Victor P Kolosov, Juliy M Perelman.   

Abstract

Mucus hypersecretion is a major pathophysiologic feature in chronic inflammatory airway diseases. Oxidative stress plays a pivotal role in this process. Recent studies have found that heparin has antioxidant effects which can reduce free radical damage. Here, we hypothesized that heparin has some influence on the expression of mucin 5AC (MUC5AC) induced by phorbol myristate acetate (PMA) in a bronchial epithelial cell line (HBE16), also we have investigated the potential mechanism involved in the process. We found that ROS, the mRNA of Duox1, EGFR and MUC5AC, as well as the protein levels of Duox1, p-EGFR, EGFR, and MUC5AC in the PMA group were significantly increased when compared with the control group (all P < 0.01). After pretreatment with heparin however, there was a significant decrease in ROS levels, the mRNA of Duox1, EGFR, and MUC5AC, and the protein levels of Duox1, p-EGFR, EGFR, and MUC5AC, when compared with the PMA group (all P < 0.01). MUC5AC protein in the supernatant was inhibited in a dose-dependent manner by heparin. Pretreatment with DMTU resulted in a significant decrease in ROS content, the mRNA of Duox1, EGFR, and MUC5AC as well as the protein levels of Duox1, p-EGFR, EGFR, and MUC5AC when compared with the PMA group (all P < 0.01). When cells were pretreated with both heparin and DMTU, there was a further reduction in ROS content, the mRNA of Duox1, EGFR, and MUC5AC as well as the protein levels of Duox1, p-EGFR, EGFR, and MUC5AC, when compared with either the PMA group, heparin group, or DMTU group (all P < 0.01). Our results show that PMA can induce MUC5AC expression by activation of the Duox1-ROS-TACE-TGF-α-EGFR signaling pathway. Heparin can decrease the level of Duox1, ROS production and block the PMA-induced activation of EGFR, thus inhibiting the overexpression of mucin MUC5AC in a dose-dependent manner. In addition to reducing ROS production, heparin may also inhibit the expression of MUC5AC through other signal mechanisms.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21984036     DOI: 10.1007/s11010-011-1078-9

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  30 in total

1.  Comparison of anticoagulant and anti-inflammatory responses using enoxaparin versus unfractionated heparin for transesophageal echocardiography-guided cardioversion of atrial fibrillation.

Authors:  Debra Hoppensteadt; Jawed Fareed; Allan L Klein; Susan E Jasper; Carolyn Apperson-Hansen; Elizabeth A Lieber; William E Katz; Joseph F Malouf; Marcus F Stoddard; Linda A Pape
Journal:  Am J Cardiol       Date:  2008-07-09       Impact factor: 2.778

2.  MUC5AC, but not MUC2, is a prominent mucin in respiratory secretions.

Authors:  H W Hovenberg; J R Davies; A Herrmann; C J Lindén; I Carlstedt
Journal:  Glycoconj J       Date:  1996-10       Impact factor: 2.916

3.  Low-molecular-weight heparin (enoxaparin) as adjuvant therapy in the treatment of active ulcerative colitis: a randomized, controlled, comparative study.

Authors:  P Zezos; G Papaioannou; N Nikolaidis; K Patsiaoura; A Papageorgiou; T Vassiliadis; O Giouleme; N Evgenidis
Journal:  Aliment Pharmacol Ther       Date:  2006-05-15       Impact factor: 8.171

4.  Epidermal growth factor system regulates mucin production in airways.

Authors:  K Takeyama; K Dabbagh; H M Lee; C Agustí; J A Lausier; I F Ueki; K M Grattan; J A Nadel
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

Review 5.  Heparin in the treatment of burns: a review.

Authors:  M J Saliba
Journal:  Burns       Date:  2001-06       Impact factor: 2.744

Review 6.  Roles of epidermal growth factor receptor activation in epithelial cell repair and mucin production in airway epithelium.

Authors:  P-R Burgel; J A Nadel
Journal:  Thorax       Date:  2004-11       Impact factor: 9.139

7.  Mast cells contribute to autoimmune inflammatory arthritis via their tryptase/heparin complexes.

Authors:  Kichul Shin; Peter A Nigrovic; James Crish; Eric Boilard; H Patrick McNeil; Katherine S Larabee; Roberto Adachi; Michael F Gurish; Reuben Gobezie; Richard L Stevens; David M Lee
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

8.  Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors.

Authors:  H Daub; F U Weiss; C Wallasch; A Ullrich
Journal:  Nature       Date:  1996-02-08       Impact factor: 49.962

9.  Preventing bronchoconstriction in exercise-induced asthma with inhaled heparin.

Authors:  T Ahmed; J Garrigo; I Danta
Journal:  N Engl J Med       Date:  1993-07-08       Impact factor: 91.245

10.  Proteolytic fragmentation and peptide mapping of human carboxyamidomethylated tracheobronchial mucin.

Authors:  M C Rose; B Kaufman; B M Martin
Journal:  J Biol Chem       Date:  1989-05-15       Impact factor: 5.157

View more
  4 in total

Review 1.  Molecular mechanisms underlying chronic inflammation-associated cancers.

Authors:  Yongzhong Wu; Smitha Antony; Jennifer L Meitzler; James H Doroshow
Journal:  Cancer Lett       Date:  2013-08-26       Impact factor: 8.679

2.  Rhythmic pressure waves induce mucin5AC expression via an EGFR-mediated signaling pathway in human airway epithelial cells.

Authors:  Chunyi Liu; Qi Li; Xiangdong Zhou; Victor P Kolosov; Juliy M Perelman
Journal:  DNA Cell Biol       Date:  2013-06-15       Impact factor: 3.311

3.  Therapeutic Anticoagulation with Argatroban and Heparins Reduces Granulocyte Migration: Possible Impact on ECLS-Therapy?

Authors:  Andre Bredthauer; Manuel Kopfmueller; Michael Gruber; Sophie-Marie Pfaehler; Karla Lehle; Walter Petermichl; Timo Seyfried; Diane Bitzinger; Andreas Redel
Journal:  Cardiovasc Ther       Date:  2020-04-25       Impact factor: 3.023

4.  ADAM17 and EGFR regulate IL-6 receptor and amphiregulin mRNA expression and release in cigarette smoke-exposed primary bronchial epithelial cells from patients with chronic obstructive pulmonary disease (COPD).

Authors:  Marta Stolarczyk; Gimano D Amatngalim; Xiao Yu; Mieke Veltman; Pieter S Hiemstra; Bob J Scholte
Journal:  Physiol Rep       Date:  2016-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.